Pharmaceutical Advertising Targeting Children: A Comparative Perspective From Poland and Selected European Countries
Acta Poloniae Pharmaceutica - Drug Research · 16.07.2026 · 84 (2) · 167-175
DOI: 10.32383/appdr/224162 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Poloniae Pharmaceutica - Drug Research, online erschienen am 16.07.2026. Verfasst von Marta Kończak und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Advertising of medicinal products during children’s television programming is strictly regulated in Poland (Article 53, paragraph 3 of the Pharmaceutical Law) and other European Union member states, where targeting pharmaceutical messages at minors is prohibited. This study aimed to verify the presence, frequency, and duration of pharmaceutical advertisements in children's programming, comparing Poland with Spain, France, Italy, Germany, Denmark, and Sweden. The material consisted of publicly available broadcasts from selected children's channels: in Poland (July-August 2024), in other countries (November 2024), and in all locations again (December 2024). During each of these periods, observers analysed selected, randomly chosen 60-minute broadcast segments aired between 7:00 AM and 8:00 PM, recording total advertising time and pharmaceutical spot duration. Advertised products were classified into therapeutic groups (e.g., analgesics, vitamins, cold remedies). Pharmaceutical advertising directed at children was found only in Poland and Spain. In Poland, such ads represented 22.3% of total advertising time in summer 2024 (2 min 11 s of 9 min 46 s) and 14.6% in December 2024 (38 s of 4 min 22 s). In Spain, a single instance occurred in November 2024, representing 13.7% (20s of 2 min 25s) of total advertising time. No pharmaceutical advertisements targeting children were detected in France, Italy, Germany, Denmark, or Sweden. Pharmaceutical advertising during children’s programming persists in Poland despite legal restrictions, suggesting insufficient enforcement. In contrast, the absence of such content in other EU countries indicates effective regulation and oversight that protect minors from exposure to pharmaceutical marketing.
Zitieren
APA
Kończak, M., Kowal, W., Ratajczak, P., Paczkowska, A., Kopciuch, D., Cynar, J., Maciuszek-Bartkowska, B., Kus, K., & Zaprutko, T. (2026). Pharmaceutical Advertising Targeting Children: A Comparative Perspective From Poland and Selected European Countries. Acta Poloniae Pharmaceutica - Drug Research, 84(2), 167-175. https://doi.org/10.32383/appdr/224162
Vancouver
Kończak M, Kowal W, Ratajczak P, Paczkowska A, Kopciuch D, Cynar J, et al. Pharmaceutical Advertising Targeting Children: A Comparative Perspective From Poland and Selected European Countries. Acta Poloniae Pharmaceutica - Drug Research. 2026;84(2):167-175. doi:10.32383/appdr/224162
BibTeX
@article{Koczak2026,
author = {Kończak, Marta and Kowal, Witold and Ratajczak, Piotr and Paczkowska, Anna and Kopciuch, Dorota and Cynar, Julia and Maciuszek-Bartkowska, Barbara and Kus, Krzysztof and Zaprutko, Tomasz},
title = {Pharmaceutical Advertising Targeting Children: A Comparative Perspective From Poland and Selected European Countries},
journal = {Acta Poloniae Pharmaceutica - Drug Research},
year = {2026},
volume = {84},
number = {2},
pages = {167--175},
doi = {10.32383/appdr/224162}
}
EUVIMED